MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 36 filers reported holding MEDICINES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,146,000 | +20.5% | 29,070,000 | 0.0% | 0.46% | +15.3% |
| Q1 2019 | $29,169,000 | +183.6% | 29,070,000 | +144.1% | 0.40% | +221.0% |
| Q4 2018 | $10,285,000 | -87.5% | 11,910,000 | -84.4% | 0.12% | -87.0% |
| Q3 2018 | $82,074,000 | +30.8% | 76,410,000 | +47.9% | 0.95% | +17.5% |
| Q2 2018 | $62,769,000 | +16.7% | 51,660,000 | +10.7% | 0.81% | +16.7% |
| Q1 2018 | $53,798,000 | +27.9% | 46,660,000 | +17.7% | 0.70% | +63.4% |
| Q4 2017 | $42,069,000 | +212.4% | 39,660,000 | +272.1% | 0.43% | +185.9% |
| Q3 2017 | $13,467,000 | -78.2% | 10,657,000 | -77.5% | 0.15% | -81.0% |
| Q2 2017 | $61,720,000 | -46.1% | 47,410,000 | -34.5% | 0.78% | -55.9% |
| Q1 2017 | $114,404,000 | +23.6% | 72,400,000 | -5.9% | 1.78% | +48.5% |
| Q4 2016 | $92,561,000 | +12.0% | 76,900,000 | +20.3% | 1.20% | -3.2% |
| Q3 2016 | $82,663,000 | +563.3% | 63,900,000 | +508.6% | 1.24% | +553.4% |
| Q2 2016 | $12,462,000 | – | 10,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 47,379,000 | $71,926,000 | 4.89% |
| Graham Capital Management, L.P. | 84,032,000 | $127,399,000 | 4.16% |
| Worth Venture Partners, LLC | 3,111,000 | $4,731,000 | 2.70% |
| CSS LLC/IL | 23,479,000 | $35,557,000 | 2.28% |
| DLD Asset Management, LP | 22,000,000 | $33,509,000 | 1.70% |
| Opti Capital Management, LP | 5,500 | $8,351,000 | 1.44% |
| EQUITEC SPECIALISTS, LLC | 3,849,000 | $5,785,000 | 1.33% |
| Verition Fund Management LLC | 16,967,000 | $25,567,000 | 0.70% |
| Nicholas Investment Partners, LP | 5,255,000 | $7,899,000 | 0.66% |
| Shaolin Capital Management LLC | 2,500,000 | $3,794,000 | 0.58% |